Cellular Therapy Clinical Trial Support Service

ACCT supports early through late phase cellular therapy clinical trials across hematologic malignancies and solid tumors, including chimeric-antigen receptor (CAR) T cells, tumor infiltrating lymphocytes (TIL), and T cell receptor transduced T cells (TCR-T).

Services include:

• End to end chain of identity (COI) and chain of custody (COC) management.
• ISBT 128 compliant labeling.
• Packaging and shipment of apheresis materials to third party manufacturers.
• Receipt, inspection, and secure storage of investigational drug products in LN₂ or −80°C environments.
• Coordination of drug product thaw and reinfusion for inpatient and outpatient settings.